News Search Results
Aug 14, 2024, 03:47 ET Genotyping Market to Reach $61.6 Billion, Globally, by 2033 at 13.8% CAGR: Allied Market Research
Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, and Others), Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics and Others), and End User (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, and Others):
More news about: Allied Market Research
Aug 13, 2024, 17:45 ET Immunodiagnostics Market size is set to grow by USD 29.54 billion from 2024-2028, Increased demand for biomarker-based tests boost the market, Technavio
impact patient care and market growth during the forecast period.The Immunodiagnostics Market faces several challenges in the areas of biotechnology, natural based materials, and organisms. Natural processes and biomolecules like proteins are key components, but sourcing reliable plant material
More news about: Technavio
Aug 13, 2024, 16:30 ET TC BioPharm Announces Pricing of $2.0 Registered Direct Offering
Aug. 13, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced it has entered into definitive
More news about: TC BioPharm
Aug 13, 2024, 16:05 ET Armata Pharmaceuticals Announces Second Quarter 2024 Results and Provides Corporate Update
Aug. 13, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on high-purity, pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections,
More news about: Armata Pharmaceuticals, Inc.
Aug 13, 2024, 14:15 ET Concept Matrix Solutions Receives Patent Approval for its Oral Soft Gel Capsule Containing Psychedelic Compound
Aug. 13, 2024 /PRNewswire/ -- Concept Matrix Solutions, Inc. ("CMS") or the ("Company"), a privately held vertically integrated biotechnology company dedicated to developing and manufacturing innovative delivery forms in both pharmaceutical and nutraceutical spaces today announced that
More news about: CONCEPT MATRIX SOLUTIONS
Aug 13, 2024, 09:04 ET South University Board of Managers Appoints Biotech CEO Adriann Sax as New Chair
the appointment of Adriann Sax as the new chair of its Board of Managers. With over 25 years of executive experience in the biopharmaceutical and biotechnology industries, Sax brings a wealth of knowledge and strategic vision that will greatly benefit the university's ongoing growth and development.
More news about: South University
Aug 13, 2024, 09:00 ET PINKDX APPOINTS DR. ROBERT S. EPSTEIN TO ITS BOARD OF DIRECTORS
women who present with general symptoms that could signal a gynecological cancer. PinkDx is privately held, with Series A funding from prominent biotechnology investors, including Catalio Capital Management, The Production Board, Mountain Group Partners, Byers Capital and Mayo Clinic. The company's operations
More news about: PinkDx
Aug 13, 2024, 09:00 ET Kytopen Receives Prestigious Phase II SBIR Award of $1.6M from the NIAID/NIH to Support Pivotal In Vivo Studies of Engineered Natural Killer Cells
Cambridge, Massachusetts with an R&D site in Denver, Colorado, is a leading biotechnology company specializing in the development and commercialization of non-viral continual flow cellular engineering platforms to accelerate the processes
More news about: Kytopen
Aug 13, 2024, 08:30 ET Pathalys Pharma Appoints Dr. Bastian Dehmel as Chief Medical Officer
role in advancing our lead asset, upacicalcet, towards a successful clinical and regulatory outcome." Dr. Dehmel brings 20 years of global biotechnology and pharmaceutical industry experience, spanning all phases of drug development, clinical operations, biostatistics, and regulatory across multiple
More news about: Pathalys Pharma
Aug 13, 2024, 08:15 ET Tevard Biosciences to Move Corporate Headquarters to Lilly Gateway Labs in Boston's Seaport
Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today announced that it will be moving its corporate headquarters
More news about: Tevard Biosciences
Aug 13, 2024, 08:08 ET Artax Biopharma completes patient recruitment in Phase 2a trial with first-in-class Nck modulator AX-158
Mass., Aug. 13, 2024 /PRNewswire/ -- Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces the completion of patient recruitment for its Phase 2a clinical
More news about: Artax Biopharma
Aug 13, 2024, 08:01 ET NeuroBo Pharmaceuticals Completes Enrollment of the SAD Part 1 of Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the completion of enrollment of the single ascending dose (SAD) Part 1
More news about: NeuroBo Pharmaceuticals, Inc.
Aug 13, 2024, 08:00 ET Lilly opens state-of-the-art research and development center in the Boston Seaport
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Aug 13, 2024, 03:33 ET Shoolini University Climbs NIRF Rankings, Secures 70th Spot in India
with the tools they need to excel in their chosen fields." About Shoolini University Set up in 2009, Shoolini University of Biotechnology and Management Sciences is a research-driven private university with full recognition from the UGC. As the No.1 Private University in India
More news about: Shoolini University
Aug 13, 2024, 02:32 ET Regenics AS completes first tranche of a NOK 54 M private placement to initiate Collex® clinical trials
Norway, Aug. 13, 2024 /PRNewswire/ -- Regenics AS, a private Norwegian biotechnology company based in Oslo (the "Company"), today announced that it has closed the first tranche of a non-brokered private
More news about: Regenics AS
Aug 12, 2024, 21:39 ET Registrational Phase III Study of Lisaftoclax in Newly-Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome Cleared by China CDE
has built a portfolio of global intellectual property rights and entered into global partnerships and other relationships with numerous leading biotechnology and pharmaceutical companies such as Takeda, AstraZeneca, Merck, Pfizer and Innovent; and research and development relationships with leading research
More news about: Ascentage Pharma
Aug 12, 2024, 19:46 ET Celltrion USA announces incorporation of adalimumab-aaty, a Humira® biosimilar, to the Costco Member Prescription Program
YUFLYMA®(adalimumab-aaty) as well as a new biologic ZYMFENTRA™. Celltrion USA will continue to leverage Celltrion's unique heritage in biotechnology, supply chain excellence and best-in-class sales capabilities to improve access to high-quality biopharmaceuticals for U.S. patients. For more information,
More news about: Celltrion USA
Aug 12, 2024, 19:15 ET The Inner Circle acknowledges, Daniel Briggs as a Pinnacle Professional Member Inner Circle of Excellence
Revolutionizing Mesenchymal Stem Cell Treatments in Human Biologics. Auragens, a pioneering company at the forefront of Human Biologics, Biotechnology, and Nanotech is making remarkable strides in revolutionizing stem cell treatments under the dynamic leadership of Dr. Daniel
More news about: The Inner Circle
Aug 12, 2024, 18:45 ET Laboratory Shaker Market size is set to grow by USD 759.5 million from 2024-2028, Increased use of laboratory shakers in various applications boost the market, Technavio
Instruments (Cambridge) Ltd., Heidolph Instruments GmbH and CO. KG, IKA Werke GmbH and CO. KG, JEIOTECH, OHAUS Corp., Perkin Elmer Inc., Santa Cruz Biotechnology Inc., Scilogex LLC, Spectra Lab Instruments Pvt. Ltd., Thermo Fisher Scientific Inc., and Union Scientific LLC.
More news about: Technavio
Aug 12, 2024, 10:30 ET Long-Read Sequencing Market worth $3,129 million in 2029 driven by Technological Advancements | MarketsandMarkets™
Oxford Nanopore Technologies plc: Leader in Long-Read Sequencing Solutions Oxford Nanopore Technologies plc (UK) is a prominent biotechnology company specializing in proprietary platforms for long-read sequencing. With a robust presence in over 100 countries, the company serves clinical,
More news about: MarketsandMarkets
Aug 12, 2024, 10:01 ET Stem Cell Therapy Market is expected to generate a revenue of USD 31.41 Billion by 2030, Globally, at 13.95% CAGR: Verified Market Research®
Stem Cell Therapy Market, by End-UserHospitals and ClinicsResearch InstitutionsBiotechnology and Pharmaceutical CompaniesStem Cell Therapy Market, by GeographyNorth
More news about: Verified Market Research
Aug 12, 2024, 08:30 ET Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial
responders and global clinical assessment scores. About Actinogen Medical Actinogen Medical (ACW) is an ASX-listed, biotechnology company developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. There is a strong
More news about: Actinogen Medical Limited
Aug 12, 2024, 08:00 ET Persist AI and Nivagen to Collaborate on AI-Driven Manufacturing Process for Long-Acting Injectable
www.persist-ai.com) is a biotechnology company that develops drug delivery systems using AI-driven robotics. The company's technology enables rapid and efficient optimization of drug
More news about: Persist AI Formulations
Aug 12, 2024, 08:00 ET Crown Laboratories and Revance Announce Entry Into Merger Agreement
Inc. ("Crown"), a privately held, global innovative leader in the skincare industry, and Revance Therapeutics, Inc. ("Revance") (NASDAQ: RVNC), a biotechnology company aimed at setting the new standard in healthcare with innovative aesthetic and therapeutic offerings, today announced that they have entered
More news about: Crown Laboratories, Inc.
Aug 12, 2024, 07:00 ET WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Aug. 12, 2024 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable functional ingredients, today released its financial
More news about: Willow Biosciences Inc.